Antares Pharma, Inc. (ATRS)

[jab91252]

Lets also remember the detail of the Rasuvo device itself. It is basically an 'off-the shelf' hand injector modified with a button for activation. State of the art injector? Not hardly. RA sufferers with impaired hand function CANNOT use the device. It is triggered by a button that has to be pressed by the thumb.

Is any one else as tired as I am about comments that Rasuvo will be so successful (and from many posts on the pos ymb, wildly successful RIGHT OUT OF THE GATE versus Otrexup), when they have yet to form a sales force, market their product and start showing scripts week over week/month over month?

Did Antares envision competition in this space? Yep, per many past 10-k's noting specifically Medac. Was that potential competition factored into their own proforma? Yep. Has Antares screwed up on anything with their product and launch? Yep. Did and are they learning from the mechanics of their launch? Yep. Are they "tweaking" things as they discover them along the way, just like LeRoux Jooste stated in the RBC Conference back in February? Yep. Is Antares perfect in everything they do? Nope. Do they learn? Yep.

Welcome to the art of doing business in the real world. The aspect of business dynamics is not unique to company Antares and of which will also be encountered by Medac with an inferior (when compared side by side to Antares' Vibex device. Remember as well, Medac is not a device maker, Antares is and develops devices to work with specific drugs AND THE END USER PATIENT.